Fecal microbiota transplantation for immunotherapy‐resistant urological tumors: Is it time? An update of the recent literature

Cost‐Effectiveness Analysis of Sequential Fecal Microbiota Transplantation for Fulminant C. difficile Infection

(2021) Sanchit Gupta et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

(2021) Diwakar Davar et al.   SCIENCE

Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials

(2020) M. Chalabi et al.   ANNALS OF ONCOLOGY

Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

(2020) Lisa Derosa et al.   EUROPEAN UROLOGY

Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices

(2020) Qiang Tang et al.   Frontiers in Cellular and Infection Microbiology

Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes

(2020) Mélanie Claps et al.   CANCER TREATMENT REVIEWS

Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

(2020) Ashley M. Hopkins et al.   EUROPEAN UROLOGY

Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers

(2020) Jennifer L. McQuade et al.   Current Oncology Reports

Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

(2020) Ashley M. Hopkins et al.   CLINICAL CANCER RESEARCH

Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors

(2020) Nicholas J. Salgia et al.   EUROPEAN UROLOGY

Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy

(2020) Vyara Matson et al.   GASTROENTEROLOGY

Can the success with immunotherapy in metastatic urothelial bladder carcinoma be replicated in the neoadjuvant setting?

(2020) Fouad Aoun et al.   Immunotherapy

Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing

(2020) Junpeng Wang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

(2020) Erez N. Baruch et al.   SCIENCE

Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand?

(2020) Simone Albisinni et al.   Minerva Urologica E Nefrologica

The Microbiome and Genitourinary Cancer: A Collaborative Review

(2019) Mark C. Markowski et al.   EUROPEAN UROLOGY

Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action

(2019) Ni Zhang et al.   Immunotherapy

The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients

(2019) Yueping Jin et al.   Journal of Thoracic Oncology

Immune checkpoint inhibition for the treatment of renal cell carcinoma

(2019) Viktoria Stühler et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

(2018) L Derosa et al.   ANNALS OF ONCOLOGY

Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer

(2018) Michael A. Liss et al.   EUROPEAN UROLOGY

Microbiome: Gut microbiota sways response to cancer immunotherapy

(2018) Ashley York   NATURE REVIEWS MICROBIOLOGY

Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies

(2018) Karen S. Sfanos et al.   PROSTATE CANCER AND PROSTATIC DISEASES

The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

(2018) Vyara Matson et al.   SCIENCE

Microbiota transplantation: concept, methodology and strategy for its modernization

(2018) Faming Zhang et al.   Protein & Cell

Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China

(2018) Peng Wu et al.   Frontiers in Cellular and Infection Microbiology

Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians

(2018) Celeste Allaband et al.   Clinical Gastroenterology and Hepatology

Fecal microbiota transplantation: Review and update

(2018) Jiunn-Wei Wang et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis

(2018) Shaheen Alanee et al.   PROSTATE

An insight into gut microbiota and its functionalities

(2018) Atanu Adak et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Fecal microbiota transplantation in cancer management: Current status and perspectives

(2018) Danfeng Chen et al.   INTERNATIONAL JOURNAL OF CANCER

Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

(2018) Cheng Xu et al.   BMJ-British Medical Journal

Estrogen–gut microbiome axis: Physiological and clinical implications

(2017) James M. Baker et al.   MATURITAS

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

(2017) V. Gopalakrishnan et al.   SCIENCE

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

(2017) Bertrand Routy et al.   SCIENCE

Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family

(2016) Frank A. Schildberg et al.   IMMUNITY

Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges

(2016) Chrisann Kyi et al.   Immunotherapy

Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma

(2016) Jarrett J. Failing et al.   MELANOMA RESEARCH

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis

(2016) Krista Dubin et al.   Nature Communications

Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?

(2015) Ben Boursi et al.   EUROPEAN JOURNAL OF CANCER

The microbiome of the urinary tract—a role beyond infection

(2015) Samantha A. Whiteside et al.   Nature Reviews Urology

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

(2015) A. Sivan et al.   SCIENCE

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

(2015) M. Vetizou et al.   SCIENCE